Celldex Therapeutics reported $0 in Debt for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Agenus AGEN:US $ 19.78M 0.59M
Amgen AMGN:US $ 32782M 97M
Applied Genetic Technologies AGTC:US $ 19.95M 9.97M
Aptinyx Inc APTX:US $ 0 0
Arena Pharmaceuticals ARNA:US $ 43.5M 1.09M
Biocept BIOC:US $ 3.11M 0.11M
Bristol Myers Squibb BMY:US $ 45158M 1124M
Celldex Therapeutics CLDX:US $ 0M 0M
Cytrx CYTR:US 0 0
Glaxosmithkline GSK:US $ 25483M 736M
Immunogen IMGN:US $ 1.1M 1M
Merrimack Pharmaceuticals MACK:US $ 0 0
Nektar Therapeutics NKTR:US $ 0M 0M
Newlink Genetics NLNK:US $ 0M 0M
Northwest Biotherapeutics NWBO:US 20.05M 985K
Rigel Pharmaceuticals RIGL:US $ 19.86M 0.02M
Seattle Genetics SGEN:US $ 0M 0M